Potential Sickle Cell Cure Has HHS Pondering How to Pay for It

May 29, 2019

The nation’s Medicare and Medicaid agency is mulling how to pay for a costly gene therapy procedure that could potentially cure sickle cell disease for 100,000 Americans.

Related Stories